Showing results (71-80 of 112) with videos related to

Sort By:
Pageof 12
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 3, 2025
Low- and High-Volume Disease in Metastatic Hormone-Sensitive Prostate Cancer: From CHAARTED to PSMA PET-An International Multicenter Retrospective StudyLena M Unterrainer, Thomas A Hope, Wolfgang P Fendler, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 11, 2023
Biodistribution and dosimetry for combined [<sup>177</sup>Lu]Lu-PSMA-I&T/[<sup>225</sup>Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imagingAstrid Delker, Mirjam Schleske, Grigory Liubchenko, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 13, 2022
Combination of pre-treatment dynamic [<sup>18</sup>F]FET PET radiomics and conventional clinical parameters for the survival stratification in patients with IDH-wildtype glioblastomaZhicong Li, Adrien Holzgreve, Lena M Unterrainer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 2, 2026
Dosimetry Analysis of <sup>177</sup>Lu-PSMA-I&T in Patients with Low-Volume Oligometastatic Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the LUNAR TrialZachary Ells, Catherine Meyer, Koichiro Kimura, et al.
Urologia Internationalis|January 19, 2026
Extended versus Standard Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Cohort StudyCan Aydogdu, Florian Urban, Elena Berg, et al.
Radiation Oncology (London, England)|April 23, 2020
Recent advances of PET imaging in clinical radiation oncologyM Unterrainer, C Eze, H Ilhan, et al.
Cancers|June 13, 2025
Changes of Prostate-Specific Membrane Antigen-Radioligand Uptake on PET with Systemic Therapy in Patients with Metastatic Renal Cell CarcinomaSophie Carina Kunte, Adrien Holzgreve, Marcus Unterrainer, et al.
EJNMMI Physics|April 13, 2026
Investigation of iterative deconvolution in <sup>177</sup>Lu-SPECT imaging for lesion dosimetryZachary Ells, Grigory Liubchenko, Mikhail Rumiantcev, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 27, 2025
PET- and CT-Based Imaging Criteria for Response Assessment of Gastroenteropancreatic Neuroendocrine Tumors Under Radiopharmaceutical TherapyFelix L Herr, Christian Dascalescu, Matthias P Fabritius, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 23, 2023
Metabolic patterns on [<sup>18</sup>F]FDG PET/CT in patients with unresectable stage III NSCLC undergoing chemoradiotherapy ± durvalumab maintenance treatmentAdrien Holzgreve, Julian Taugner, Lukas Käsmann, et al.
Pageof 12